Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 02, 2015 07:30 ET | Source: Dermira, Inc.

Dermira Announces Poster Presentation on DRM01 in Acne at World Congress of Dermatology

MENLO PARK, Calif., June 2, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and...
May 28, 2015 07:30 ET | Source: Dermira, Inc.

Dermira to Present at Jefferies 2015 Global Healthcare Conference

MENLO PARK, Calif., May 28, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and...
May 12, 2015 16:13 ET | Source: Dermira, Inc.

Dermira Reports First Quarter 2015 Financial Results and Provides Corporate Update

MENLO PARK, Calif., May 12, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and...
April 09, 2015 07:30 ET | Source: Dermira, Inc.

Dermira Doses First Patient in DRM01 Phase 2b Acne Trial

MENLO PARK, Calif., April 9, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists...
April 08, 2015 07:30 ET | Source: Dermira, Inc.

Dermira to Present at the 14th Annual Needham Healthcare Conference

MENLO PARK, Calif., April 8, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists...
March 25, 2015 16:09 ET | Source: Dermira, Inc.

Dermira Reports Fourth Quarter and Full Year 2014 Financial Results and Provides Corporate Update

DRM01 Phase 2b Trial in Acne to Start April 2015 Conference Call Today at 4:30 p.m. Eastern Time MENLO PARK, Calif., March 25, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty...
March 23, 2015 07:00 ET | Source: Dermira, Inc.

Clinical Data for Dermira's DRM01 Acne Program Presented at Dermatology Meeting

MENLO PARK, Calif., March 23, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists...
March 18, 2015 16:05 ET | Source: Dermira, Inc.

Dermira to Report Fourth Quarter and Full Year 2014 Financial Results

MENLO PARK, Calif., March 18, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated dermatology products to...
March 12, 2015 16:05 ET | Source: Dermira, Inc.

Dermira Announces Late-Breaking Oral Presentation on DRM01 in Acne at 2015 AAD Annual Meeting

MENLO PARK, Calif., March 12, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists...
February 05, 2015 16:05 ET | Source: Dermira, Inc.

Dermira Announces Positive Phase 2b Results for DRM04 in Patients With Hyperhidrosis

MENLO PARK, Calif., Feb. 5, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and...